Evidence map›Paper›PMID 41465155›Full record

ArticleGenes2025

WES-Based Screening of a Swedish Patient Series with Parkinson's Disease.

Efthymia Kafantari, Kajsa Atterling Brolin, Joel Wallenius, Maria Swanberg, Andreas Puschmann

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Rare TruncatingGenes · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Efthymia KafantariDivision of Neurology, Department of Clinical Sciences Lund, Lund University, 221 00 Lund, Sweden.
Kajsa Atterling BrolinTranslational Neurogenetics Unit, Department of Experimental Medical Science, Lund University, 221 00 Lund, Sweden.
Joel WalleniusDivision of Neurology, Department of Clinical Sciences Lund, Lund University, 221 00 Lund, Sweden.
Maria SwanbergTranslational Neurogenetics Unit, Department of Experimental Medical Science, Lund University, 221 00 Lund, Sweden.ORCID 0000-0002-1829-1008
Andreas PuschmannDivision of Neurology, Department of Clinical Sciences Lund, Lund University, 221 00 Lund, Sweden.ORCID 0000-0002-3201-8198

Funding

Infrastructure support from MultiPark-a strategic research environment at Lund University, Sweden No grant numberRegion Skåne No grant numberSkåne University Hospital No grant numberThe Swedish government (via ALF, avtal för läkarutbildning och forskning) No grant numberThe Swedish Parkinson Academy No grant numberThe Swedish Parkinson Foundation (Parkinsonfonden) No grant number
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Exome SequencingParkinson DiseaseAdultAgedalpha-SynucleinFemaleGenetic Predisposition to DiseaseGenetic TestingGlucosylceramidaseHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MaleMiddle AgedMutationPedigreeSwedenalpha-SynucleinGBA protein, humanGlucosylceramidaseLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanSNCA protein, humanVesicular Transport ProteinsVPS35 protein, humangenetic investigationParkinson’s diseasewhole-exome sequencing

Identifiers

PMID41465155
PMCPMC12732595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.